Cargando…
Reassessing Rabbit Antithymocyte Globulin Induction in Kidney Transplantation (RETHINK): An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry
BACKGROUND. There is no consensus on rabbit antithymocyte globulin (rATG) dose used for induction immunosuppression in pediatric kidney transplants. We aimed to identify whether a lower rATG dose provides safe and effective immunosuppression compared with a higher dose. METHODS. We retrospectively a...
Autores principales: | Ashoor, Isa F., Martz, Karen, Galbiati, Shirley, Beyl, Robbie A., Dharnidharka, Vikas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447457/ https://www.ncbi.nlm.nih.gov/pubmed/32903852 http://dx.doi.org/10.1097/TXD.0000000000001042 |
Ejemplares similares
-
Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation
por: Singh, Namita, et al.
Publicado: (2018) -
Retrospective Evaluation of Rabbit Antithymocyte Globulin Induction in Heart Transplant Patients
por: Lee, Grace Pui-Yun, et al.
Publicado: (2022) -
Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research Consortium
por: Ashoor, Isa F., et al.
Publicado: (2021) -
Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
por: Lakkaraja, Madhavi, et al.
Publicado: (2022) -
Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
por: Lam, Ngan N., et al.
Publicado: (2021)